This was in agreement with the co-immunoprecipitation (co-IP) assay, which illustrated the direct interaction between FGFR2 and CLDN1 in GIST lysates precipitated with anti-CLDN1 mAbs and probed for FGFR2 (Figure 6B). Here, FGFR2 is linked to gastrointestinal stromal tumor.